11 EU medtech notified bodies sign up to voluntary code of conduct
This article was originally published in Clinica
A group of 11 European notified bodies – called the NB Plus Group – have signed up to the recently-agreed voluntary code of conduct for medical device notified bodies.
You may also be interested in...
Citing challenges posed by the COVID-19 pandemic, EU regulators have extended the deadline for companies to finish nitrosamine-related risk evaluations.
The Australian health care products regulator is inviting feedback on proposed measures to clarify the boundary for software-based products that are captured under the regulatory framework for medical devices.
A draft EU guideline explains how companies can ensure that data from ongoing clinical trials remains relevant for regulatory decision-making despite problems posed by the COVID-19 pandemic.